WolffReport

Swedish/German/EU Investor, Asset Manager, Writer, Analyst

Senior analyst, Wide Moat Research LLC
Contributor, Seeking Alpha

[WolffReport @ReportWolff]

My article on #Sectors that i'm avoiding in #investing for 2023 is trending!

[WolffReport @ReportWolff]

#Millicom is an interesting #emergingmarket play. If the company reaches it's goal, a 5-10x RoR isn't unlikely in the long term. #Investing

https://t.co/DYgG34Kj8H

[WolffReport @ReportWolff]

#NovoNordisk is unfortunately one of the most severely overvalued major pharma stocks out there. I would avoid it at this price at all cost.

Read more here.

https://t.co/NiJX6PmwOF

[WolffReport @ReportWolff]

#Cintas #CTAS remains unfortunately overvalued. I view it as a "HOLD" - learn why here. #Dividendinvesting

https://t.co/UxRPqUL7Ju

[WolffReport @ReportWolff]

#Polaris #PII is a great dividend stock - but most seemed to have gone in too early. Here's my take, and I'm probably going in now.

https://t.co/T4VY57Swp3

[WolffReport @ReportWolff]

I think #RyderSystems is an attractively-priced company with a great near-term future. Most of all, it's priced incorrectly for the superb earnings and quality it offers. #Dividends #Incomeinvesting

Read all about it!

https://t.co/6kbRAGB1Lc

[WolffReport @ReportWolff]

#Allianz is an attractive potential play for 2023, but is it cheap enough? After reaching over €210/share, it might be time to look at it differently.

Check out my latest take here.

https://t.co/lWBSUyIUP2

#Dividendinvesting

[WolffReport @ReportWolff]

#Principalfinancialgroup is a "HOLD" here - i view the company's valuation as stretched and believe we're in for a downside, despite the solid rating and fundamentals of the business.

https://t.co/LSKo61EsDc

[WolffReport @ReportWolff]

Here's why #Fresenius is a "BUY" to me - but i prefer the non-dialysis company with 4 segments to the FMS ticker.

https://t.co/9DC6ozD4B5

#Dividends

[WolffReport @ReportWolff]

@bradthomas @SeekingAlpha @SelfMadeMastery @JazzyLove_LCID @DairyLandDiv @DaneDividend @BarryMilligan8 @DivGrowthIncome @DividendHulk @DividendDandy @theDividendKid Bravo! Well-deserved!

[WolffReport @ReportWolff]

Scared of the dip? Here is how I intend to spend $30,000. Maybe you'll find some inspiration here. #Dividendinvesting

https://t.co/nb9aGlCRpx

[WolffReport @ReportWolff]

@bradthomas Some #O and some #STOR

[WolffReport @ReportWolff]

@theDividendKid @bradthomas @TheAlphaThought @dividend_data @DaneDividend @jimcramer @MarketsUpChuck @NPetallides Just OHI doin' its thing ;). #OmegaHealthcareInvestors

[WolffReport @ReportWolff]

The talented specialist @bradthomas and i co-produced an article on #ASML. I'd like you to read it and find out why the company is a "BUY" #dividendinvesting.

https://t.co/txhWzDbKlT

[WolffReport @ReportWolff]

The upside for both #Fresenius and #FreseniusMedicalCare is getting higher. 20-30% annually at least here, as I see it.

Read why here. #Dividendinvesting.

https://t.co/Dj8gh0uELS

[WolffReport @ReportWolff]

#BankofMontreal is a great company with a very nice upside. I believe it's a "BUY" here, and you can read why here. #Dividendinvesting.

https://t.co/7XVlZMbYbj

[WolffReport @ReportWolff]

I think that #LVMH is even more appealing now than it was a few months ago. I'm LONG LVMH! #Dividendinvesting.

https://t.co/Q94KzvMzT2

[WolffReport @ReportWolff]

@TheSharkDaymond You hire me.

[WolffReport @ReportWolff]

I recently wrote on Twilio #TWLO. A business with a great customer portfolio & products, but currently unprofitable. What are your thoughts?

https://t.co/btah1YkdAH

[WolffReport @ReportWolff]

#Unum is still a #BUY here - read why here.

https://t.co/4WUeR4sFdI